Skip to content
HCN Grants Est. 2026
No. PA-27-101 · National Institutes of Health
Open

NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)

Dealbreakers Cost share required Audit: not stated Reimbursement-only: not stated

At a glance

No plain-language summary yet for this grant — the official description below is the best source.

What it funds

  • Health
  • Technology & Product Development
  • Other / needs-review
  • Biomedical & Disease Research
Official description from grants.gov

The NIH Phase IIB Strategic Breakthrough award bridges the funding gap between the end of a Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase II award and commercialization. The Phase IIB Strategic Breakthrough provides previously funded NIH SBIR or STTR projects additional support for later-stage research and development (R&D).

Who can apply

  • Small businesses
Geographic restriction None found in the announcement — likely nationwide